Navigation Links
GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM)
Date:11/11/2013

eading position in the development of plant-derived cannabinoid therapeutics and has a deep pipeline of additional clinical-stage cannabinoid product candidates targeting epilepsy (including an orphan pediatric epilepsy program), Type 2 diabetes, ulcerative colitis, glioma and schizophrenia. For further information, please visit www.gwpharm.com.

Forward-looking statements

This news release may contain forward-looking statements that reflect GWs current expectations regarding future events, including statements regarding our clinical goals, our plans for a clinical trial, the ability to conduct clinical trials sufficient to achieve positive completion, and the therapeutic and commercial value of the company's compounds. To the degree we are able to conduct clinical trials, we may have difficulty in enrolling candidates for testing and we may not be able to achieve the desired results. Forward-looking statements involve risks and uncertainties.  Actual events could differ materially from those projected herein and depend on a number of factors, including (inter alia), the success of the GW's research strategies, the applicability of the discoveries made therein, the successful and timely completion of uncertainties related to the regulatory process, and the acceptance of Sativex® and other products by consumer and medical professionals. A further list and description of risks, uncertainties and other risks associated with an investment in GW can be found in GW's filings with the U.S. Securities and Exchange Commission, including the prospectus related to the NASDAQ offering filed by GW with the SEC on May 1, 2013. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. GW undertakes no obligation to update or revise the information contained in this press release, whether as a result o
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
3. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
4. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
5. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
6. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... NC (PRWEB) March 30, 2015 ... are pleased to announce the formation of VaxCorps, ... research centers specializing in the conduct of vaccine ... VaxCorps clinical sites have successfully conducted over ... experience in seasonal and pandemic influenza as well ...
(Date:3/30/2015)... 30, 2015  Multiple new research abstracts suggest walnuts ... health factors. From their impact on colon cancer and ... on both gut health and vascular health, the research ... latest understanding of walnuts, inner workings. Running March 28 ... this annual meeting attracts an international audience of over ...
(Date:3/30/2015)... -- Heidrick & Struggles (Nasdaq: HSII ), the premier provider ... culture shaping worldwide, today  announced that John ... Healthcare and Life Sciences practice. As Global Practice ... a team of more than 80 partners, principals and associates ... Asia serving clients in the biopharmaceutical, medical ...
(Date:3/30/2015)... Calif. , March 30, 2015  NuGene ... its subsidiary corporation, NuGene BioPharma, Inc. has added ... Dr. Guan is an internationally recognized ... finishing his college education at Peking University, ... Ph.D. degree from the University of North Carolina, ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3
... Inc. (OTC Bulletin Board: GNLK), a leading consumer genomics biotech company, today reported financial ... , , ... ... quarter gross profit improvement over Q1 2009 of 37% Q1 Revenues of  $2,221,111, a ...
... 11, 2010 The subject of extensive studies,across the world, Resveratrol is ... comes to light of the continuing,beneficial effects of this compound, a further study ... believe to,be the case - that Resveratrol could have a significant impact on ... , , ...
... WATERTOWN, Mass. , May 11 EnVivo ... in a Phase IIb study of its EVP-6124 compound, ... to moderate Alzheimer,s disease.  The multi-center, dose ranging, placebo ... Europe is designed to determine the safety ...
Cached Biology Technology:GeneLink Reports First Quarter Gains 2Can Resveratrol Make You Smarter? 2Can Resveratrol Make You Smarter? 3Can Resveratrol Make You Smarter? 4Can Resveratrol Make You Smarter? 5EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 2EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 3
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... to mention the cleaning product industry, repeatedly warn of ... microbiologist is raising the intriguing idea that persistent bacterial ... the Robert W. and Vivian K. Cahill Professor in ... in an essay in the Feb. 24 issue of ...
... In the March issue of Trends in Biotechnology, scientists ... (PCRM) recommend using only animal serum-free media to grow ... use of fetal calf serum, which is obtained by ... Recent breakthroughs permit the growth of human cells in ...
... publicized, other than by word of mouth, and still ... overwhelmed with requests. Since 1998, the school's oncology ... diagnosed with melanoma. Though it is still an ... have wanted to participate in the study, on the ...
Cached Biology News:Learning to love bacteria: Stanford scientist highlights bugs' benefits 2Learning to love bacteria: Stanford scientist highlights bugs' benefits 3Canine cancer vaccine program shows early promise 2
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Conjugate Quality Control Evaluation Specificity: Conjugate Quality Control Evaluation ...
... Service - Conjugation Alkaline ... Biotin Conjugation Fluorescein Isothiocyanate Conjugation ... Allophycocyanin Conjugation Alexa Fluor 488 Conjugation ... Fluor 405 Conjugation Rpe-Alexa Fluor 750 ...
Request Info...
Biology Products: